![](/img/cover-not-exists.png)
All-trans retinoic acid and arsenic combination therapy benefits low-to-intermediate-risk patients with newly diagnosed acute promyelocytic leukaemia: a long-term follow-up based on multivariate analysis
Zhu, Hongming, Hu, Jiong, Li, Xiaoyang, Chen, Li, Zhao, Huijin, Zhou, Wei, Wang, Lining, Zhao, Xia, Zhang, Yunxiang, Chen, Yu, Sun, Huiping, Chen, Qiusheng, Chen, Yu, Zhao, Weili, Mi, Jianqing, Shen,Volume:
171
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.13375
Date:
October, 2015
File:
PDF, 150 KB
english, 2015